{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:57:35Z","timestamp":1790657855586,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Virta Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13300-026-01909-w","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T07:04:27Z","timestamp":1786431867000},"page":"1495-1518","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Healthcare Cost Impacts of Telehealth-Delivered Nutrition Therapy among US Adults with Type 2 Diabetes or Obesity: A Matched Difference-in-Differences Analysis"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1888-1857","authenticated-orcid":false,"given":"Priya V.","family":"Shanmugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2715-649X","authenticated-orcid":false,"given":"Rebecca N.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5427-6748","authenticated-orcid":false,"given":"Shaminie J.","family":"Athinarayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Wolfberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2564-4577","authenticated-orcid":false,"given":"Jeromie M.","family":"Ballreich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"1909_CR1","unstructured":"CDC. National Diabetes Statistics Report [Internet]. 2024 [cited 2025 Sep 21]. Report No. Available from: https:\/\/www.cdc.gov\/diabetes\/php\/data-research\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html."},{"key":"1909_CR2","unstructured":"CDC. Adult Obesity Facts [Internet]. 2025 May [cited 2025 Sep 21]. Report No. Available from: https:\/\/www.cdc.gov\/obesity\/adult-obesity-facts\/index.html."},{"issue":"17","key":"1909_CR3","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1001\/jama.298.17.2028","volume":"298","author":"KM Flegal","year":"2007","unstructured":"Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA. 2007;298(17):2028\u201337. https:\/\/doi.org\/10.1001\/jama.298.17.2028. (PubMed PMID: 17986696).","journal-title":"JAMA"},{"issue":"7258","key":"1909_CR4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, et\u00a0al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321(7258):405. https:\/\/doi.org\/10.1136\/bmj.321.7258.405. (PubMedPMID:10938048;PubMedCentralPMCID:PMC27454).","journal-title":"BMJ"},{"issue":"1","key":"1909_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/dci23-0085","volume":"47","author":"ED Parker","year":"2023","unstructured":"Parker ED, Lin J, Mahoney T, Ume N, Yang G, Gabbay RA, et\u00a0al. Economic costs of diabetes in the U.S. in 2022. Diabetes Care. 2023;47(1):26\u201343. https:\/\/doi.org\/10.2337\/dci23-0085. (PubMed PMID: 37909353).","journal-title":"Diabetes Care"},{"issue":"3","key":"1909_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0247307","volume":"16","author":"ZJ Ward","year":"2021","unstructured":"Ward ZJ, Bleich SN, Long MW, Gortmaker SL. Association of body mass index with health care expenditures in the United States by age and sex. PLoS ONE. 2021;16(3):e0247307. https:\/\/doi.org\/10.1371\/journal.pone.0247307. (PubMedPMID:33760880;PubMedCentralPMCID:PMC7990296).","journal-title":"PLoS ONE"},{"key":"1909_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ahj.2023.05.002","volume":"263","author":"SV Arnold","year":"2023","unstructured":"Arnold SV, Gosch K, Kosiborod M, Wong ND, Sperling LS, Newman JD, et\u00a0al. Contemporary use of cardiovascular risk reduction strategies in type 2 diabetes. insights from the diabetes collaborative registry. Am Hear J. 2023;263:104\u201311. https:\/\/doi.org\/10.1016\/j.ahj.2023.05.002. (PubMed PMID: 37164146).","journal-title":"Am Hear J"},{"key":"1909_CR8","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.2147\/ppa.s106821","volume":"10","author":"WH Polonsky","year":"2016","unstructured":"Polonsky WH, Henry RR. Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors. Patient Pref Adher. 2016;10:1299\u2013307. https:\/\/doi.org\/10.2147\/ppa.s106821. (PubMedPMID:27524885;PubMedCentralPMCID:PMC4966497).","journal-title":"Patient Pref Adher"},{"key":"1909_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ahj.2020.03.017","volume":"224","author":"Y Gao","year":"2020","unstructured":"Gao Y, Peterson E, Pagidipati N. Barriers to prescribing glucose-lowering therapies with cardiometabolic benefits. Am Hear J. 2020;224:47\u201353. https:\/\/doi.org\/10.1016\/j.ahj.2020.03.017. (PubMed PMID: 32304879).","journal-title":"Am Hear J"},{"issue":"12","key":"1909_CR10","doi-asserted-by":"publisher","first-page":"2120","DOI":"10.2337\/dc24-0011","volume":"47","author":"KS Johansson","year":"2024","unstructured":"Johansson KS, Jimenez-Solem E, Petersen TS, Christensen MB. Increasing medication use and polypharmacy in type 2 diabetes: the danish experience from 2000 to 2020. Diabetes Care. 2024;47(12):2120\u20137. https:\/\/doi.org\/10.2337\/dc24-0011. (PubMed PMID: 38709662).","journal-title":"Diabetes Care"},{"issue":"3 Suppl","key":"1909_CR11","first-page":"S49","volume":"18","author":"DP Nau","year":"2012","unstructured":"Nau DP. Recommendations for improving adherence to type 2 diabetes mellitus therapy\u2013Focus on optimizing oral and non-insulin therapies. Am J Manag care. 2012;18(3 Suppl):S49-54 (PubMed PMID: 22558942).","journal-title":"Am J Manag care"},{"issue":"4","key":"1909_CR12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.2337\/dc14-2098","volume":"38","author":"MS Kirkman","year":"2015","unstructured":"Kirkman MS, Rowan-Martin MT, Levin R, Fonseca VA, Schmittdiel JA, Herman WH, et\u00a0al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604\u20139. https:\/\/doi.org\/10.2337\/dc14-2098. (PubMedPMID:25573883;PubMedCentralPMCID:PMC4370331).","journal-title":"Diabetes Care"},{"issue":"1","key":"1909_CR13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57349","volume":"8","author":"PJ Rodriguez","year":"2025","unstructured":"Rodriguez PJ, Zhang V, Gratzl S, Do D, Cartwright BG, Baker C, et\u00a0al. Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among US adults with overweight or obesity. JAMA Netw Open. 2025;8(1):e2457349. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.57349. (PubMedPMID:39888616;PubMedCentralPMCID:PMC11786232).","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1909_CR14","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18553\/jmcp.2024.23332","volume":"30","author":"PP Gleason","year":"2024","unstructured":"Gleason PP, Urick BY, Marshall LZ, Friedlander N, Qiu Y, Leslie RS. Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. J Manag Care Sp\u00e9c Pharm. 2024;30(8):860\u20137. https:\/\/doi.org\/10.18553\/jmcp.2024.23332. (PubMedPMID:38717042;PubMedCentralPMCID:PMC11293763).","journal-title":"J Manag Care Sp\u00e9c Pharm"},{"issue":"2","key":"1909_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13300-019-0590-x","volume":"10","author":"B Guerci","year":"2019","unstructured":"Guerci B, Chanan N, Kaur S, Jasso-Mosqueda JG, Lew E. Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes. Diabetes Ther. 2019;10(2):437\u201349. https:\/\/doi.org\/10.1007\/s13300-019-0590-x. (PubMedPMID:30850934;PubMedCentralPMCID:PMC6437240).","journal-title":"Diabetes Ther"},{"issue":"7","key":"1909_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.20724","volume":"7","author":"D Barthold","year":"2024","unstructured":"Barthold D, Li J, Basu A. Patient out-of-pocket costs for type 2 diabetes medications when aging into medicare. JAMA Netw Open. 2024;7(7):e2420724. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.20724. (PubMedPMID:38980673;PubMedCentralPMCID:PMC11234236).","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1909_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3132\/dvdr.2008.046","volume":"5","author":"JC Fruchart","year":"2008","unstructured":"Fruchart JC, Sacks FM, Hermans MP, Assmann G, Brown WV, Ceska R, et\u00a0al. The residual risk reduction initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients. Diabetes Vasc Dis Res. 2008;5(4):319\u201335. https:\/\/doi.org\/10.3132\/dvdr.2008.046. (PubMed PMID: 18958843).","journal-title":"Diabetes Vasc Dis Res"},{"issue":"12","key":"1909_CR18","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/nutrit\/nuad032","volume":"81","author":"JT Kelly","year":"2023","unstructured":"Kelly JT, Law L, Guzman KRD, Hickman IJ, Mayr HL, Campbell KL, et\u00a0al. Cost-effectiveness of telehealth-delivered nutrition interventions: a systematic review of randomized controlled trials. Nutr Rev. 2023;81(12):1599\u2013611. https:\/\/doi.org\/10.1093\/nutrit\/nuad032. (PubMedPMID:37016937;PubMedCentralPMCID:PMC10639107).","journal-title":"Nutr Rev"},{"issue":"1","key":"1909_CR19","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1001\/jamainternmed.2019.4802","volume":"180","author":"WS Yancy","year":"2020","unstructured":"Yancy WS, Crowley MJ, Dar MS, Coffman CJ, Jeffreys AS, Maciejewski ML, et\u00a0al. Comparison of group medical visits combined with intensive weight management vs group medical visits alone for glycemia in patients with type 2 diabetes. JAMA Intern Med. 2020;180(1):70\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2019.4802. (PubMedPMID:31682682;PubMedCentralPMCID:PMC6830502).","journal-title":"JAMA Intern Med"},{"issue":"12","key":"1909_CR20","doi-asserted-by":"publisher","first-page":"cat-25","DOI":"10.1056\/cat.25.0145","volume":"6","author":"NE Morden","year":"2025","unstructured":"Morden NE, Elswyk JV, Henk HJ, Pirrello AV, Docimo AB. UnitedHealthcare\u2019s approach to digitally enabled health solutions: pragmatic trials to identify real value. NEJM Catal. 2025;6(12):cat-25. https:\/\/doi.org\/10.1056\/cat.25.0145.","journal-title":"NEJM Catal"},{"key":"1909_CR21","unstructured":"CDC. National Health Statistics Report [Internet]. 2024 [cited 2025 Oct 22]. Report No. Available from: https:\/\/www.cdc.gov\/nchs\/data\/nhsr\/nhsr205.pdf."},{"key":"1909_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fendo.2019.00348","volume":"10","author":"SJ Athinarayanan","year":"2019","unstructured":"Athinarayanan SJ, Adams RN, Hallberg SJ, McKenzie AL, Bhanpuri NH, Campbell WW, et\u00a0al. Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical trial. Front Endocrinol. 2019;10:348. https:\/\/doi.org\/10.3389\/fendo.2019.00348. (PubMedPMID:31231311;PubMedCentralPMCID:PMC6561315).","journal-title":"Front Endocrinol"},{"issue":"4","key":"1909_CR23","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1177\/1559827620930962","volume":"14","author":"J Kelly","year":"2020","unstructured":"Kelly J, Karlsen M, Steinke G. Type 2 diabetes remission and lifestyle medicine: a position statement From the American College of lifestyle medicine. Am J Lifestyle Med. 2020;14(4):406\u201319. https:\/\/doi.org\/10.1177\/1559827620930962. (PubMedPMID:33281521;PubMedCentralPMCID:PMC7692017).","journal-title":"Am J Lifestyle Med"},{"issue":"2","key":"1909_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13300-018-0373-9","volume":"9","author":"SJ Hallberg","year":"2018","unstructured":"Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, et\u00a0al. Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized. Controll Study Diabetes Ther. 2018;9(2):583\u2013612. https:\/\/doi.org\/10.1007\/s13300-018-0373-9. (PubMedPMID:29417495;PubMedCentralPMCID:PMC6104272).","journal-title":"Controll Study Diabetes Ther"},{"issue":"2","key":"1909_CR25","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4140\/tcp.n.2021.112","volume":"36","author":"JV Nguyen","year":"2021","unstructured":"Nguyen JV, Roseberry S, Rivas JA, Cauthon KAB. Hypoglycemia in older people with type 2 diabetes: prevention and treatment strategies for outpatient and long-term care facility settings. Sr Care Pharm. 2021;36(2):112\u201323. https:\/\/doi.org\/10.4140\/tcp.n.2021.112.","journal-title":"Sr Care Pharm"},{"issue":"5","key":"1909_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.jcjd.2022.01.009","volume":"46","author":"Z Deng","year":"2022","unstructured":"Deng Z, Thompson W, Korenvain C, Lega IC, Farrell B, Lochnan H, et\u00a0al. Benefits and harms of deprescribing antihyperglycemics for adults with type 2 diabetes: a systematic review. Can J Diabetes. 2022;46(5):473\u20139. https:\/\/doi.org\/10.1016\/j.jcjd.2022.01.009. (PubMed PMID: 35739041).","journal-title":"Can J Diabetes"},{"issue":"5","key":"1909_CR27","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/circoutcomes.116.002901","volume":"9","author":"R Rodr\u00edguez-Guti\u00e9rrez","year":"2016","unstructured":"Rodr\u00edguez-Guti\u00e9rrez R, Montori VM. Glycemic control for patients with type 2 diabetes mellitus. Circ Cardiovasc Qual Outcomes. 2016;9(5):504\u201312. https:\/\/doi.org\/10.1161\/circoutcomes.116.002901. (PubMed PMID: 27553599; PubMed Central PMCID: PMC5031530).","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"1909_CR28","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1111\/dom.14515","volume":"23","author":"KL Strombotne","year":"2021","unstructured":"Strombotne KL, Lum J, Ndugga NJ, Utech AE, Pizer SD, Frakt AB, et\u00a0al. Effectiveness of a ketogenic diet and virtual coaching intervention for patients with diabetes: a difference-in-differences analysis. Diabetes, Obes Metab. 2021;23(12):2643\u201350. https:\/\/doi.org\/10.1111\/dom.14515. (PubMedPMID:34351035;PubMedCentralPMCID:PMC8789005).","journal-title":"Diabetes, Obes Metab"},{"issue":"6","key":"1909_CR29","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.eprac.2025.03.013","volume":"31","author":"CCL Wang","year":"2025","unstructured":"Wang CCL, Estacio R, Coronel-Mockler S, Flattery N, Hanson PD, Adams RN, et\u00a0al. Virta Intervention in CommuniTies in ColORado (VICTOR) pilot study to improve diabetes and cardiovascular risk in rural communities - Primary results. Endocr Pract. 2025;31(6):790\u20137. https:\/\/doi.org\/10.1016\/j.eprac.2025.03.013. (PubMed PMID: 40209862).","journal-title":"Endocr Pract"},{"issue":"9","key":"1909_CR30","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1111\/dom.16525","volume":"27","author":"RN Adams","year":"2025","unstructured":"Adams RN, Athinarayanan SJ, Zoller AR, McKenzie AL, Ratner RE. Sustained metabolic improvements in a remotely delivered ketogenic nutrition programme for veterans with type 2 diabetes: a 3-year observational study. Diabetes, Obes Metab. 2025;27(9):4825\u201335. https:\/\/doi.org\/10.1111\/dom.16525. (PubMedPMID:40521806;PubMedCentralPMCID:PMC12326886).","journal-title":"Diabetes, Obes Metab"},{"key":"1909_CR31","doi-asserted-by":"publisher","DOI":"10.2337\/db24-871-p","author":"CGP Roberts","year":"2024","unstructured":"Roberts CGP, Adams RN, Athinarayanan SJ, Volk BM, Zoller AR, Mckenzie AL. 871-P: one-year real-world evidence of effectiveness of carbohydrate restricted nutrition therapy in adults with type 2 diabetes across age and gender. Diabetes. 2024. https:\/\/doi.org\/10.2337\/db24-871-p.","journal-title":"Diabetes"},{"key":"1909_CR32","doi-asserted-by":"publisher","DOI":"10.2337\/db24-208-or","author":"SJ Athinarayanan","year":"2024","unstructured":"Athinarayanan SJ, Adams RN, Roberts CGP, Volk BM, Zoller A, Mckenzie AL. 208-OR: impact of carbohydrate-restricted nutrition therapy and continuous remote care among people with type 2 diabetes in rural vs. urban areas. Diabetes. 2024. https:\/\/doi.org\/10.2337\/db24-208-or.","journal-title":"Diabetes"},{"key":"1909_CR33","doi-asserted-by":"publisher","DOI":"10.2337\/db24-1063-p","author":"BM Volk","year":"2024","unstructured":"Volk BM, Athinarayanan SJ, Adams RN, Roberts CGP, Zoller AR, Mckenzie AL. 1063-P: a carbohydrate-restricted intervention and continuous remote care improves health outcomes across all socioeconomic groups at two years. Diabetes. 2024. https:\/\/doi.org\/10.2337\/db24-1063-p.","journal-title":"Diabetes"},{"issue":"3","key":"1909_CR34","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1111\/dom.15401","volume":"26","author":"KL Strombotne","year":"2024","unstructured":"Strombotne KL, Lum J, Pizer SD, Figueroa S, Frakt AB, Conlin PR. Clinical effectiveness and cost-impact after 2 years of a ketogenic diet and virtual coaching intervention for patients with diabetes. Diabetes, Obes Metab. 2024;26(3):1016\u201322. https:\/\/doi.org\/10.1111\/dom.15401. (PubMedPMID:38082469;PubMedCentralPMCID:PMC10987085).","journal-title":"Diabetes, Obes Metab"},{"key":"1909_CR35","doi-asserted-by":"publisher","DOI":"10.2337\/db22-59-lb","author":"Z Chen","year":"2022","unstructured":"Chen Z, Birse CE, Arellano AR, Fragala MS, Mcphaul MJ, Bare LA. 59-LB: outcomes of an employer-sponsored virtual type 2 diabetes (T2D) reversal program in working-age adults. Diabetes. 2022. https:\/\/doi.org\/10.2337\/db22-59-lb.","journal-title":"Diabetes"},{"key":"1909_CR36","unstructured":"KomodoHealth. The Komodo Healthcare Map [Internet]. 2021. Available from: https:\/\/www.komodohealth.com\/solutions\/healthcare-map\/."},{"issue":"4","key":"1909_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et\u00a0al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008. (PubMed PMID: 18313558).","journal-title":"J Clin Epidemiol"},{"key":"1909_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3532","volume":"363","author":"SM Langan","year":"2018","unstructured":"Langan SM, Schmidt SA, Wing K, Ehrenstein V, Nicholls SG, Filion KB, et\u00a0al. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE). BMJ. 2018;363:k3532. https:\/\/doi.org\/10.1136\/bmj.k3532. (PubMedPMID:30429167;PubMedCentralPMCID:PMC6234471).","journal-title":"BMJ"},{"key":"1909_CR39","unstructured":"Ho DE, Imai K, King G, Stuart E. {MatchIt}: Nonparametric Preprocessing for Parametric Causal Inference}, [Internet]. Available from: https:\/\/cran.r-project.org\/web\/packages\/MatchIt\/citation.html."},{"issue":"2","key":"1909_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jeconom.2021.03.014","volume":"225","author":"A Goodman-Bacon","year":"2021","unstructured":"Goodman-Bacon A. Difference-in-differences with variation in treatment timing. J Econ. 2021;225(2):254\u201377. https:\/\/doi.org\/10.1016\/j.jeconom.2021.03.014.","journal-title":"J Econ"},{"issue":"4","key":"1909_CR41","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/mlr.0000000000000653","volume":"55","author":"LM Strawbridge","year":"2017","unstructured":"Strawbridge LM, Lloyd JT, Meadow A, Riley GF, Howell BL. One-year outcomes of diabetes self-management training among medicare beneficiaries newly diagnosed with diabetes. M\u00e9d Care. 2017;55(4):391\u20137. https:\/\/doi.org\/10.1097\/mlr.0000000000000653. (PubMed PMID: 27753746).","journal-title":"M\u00e9d Care"},{"issue":"4","key":"1909_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2337\/diaspect.27.4.235","volume":"27","author":"MR Dalal","year":"2014","unstructured":"Dalal MR, Robinson SB, Sullivan SD. Real-world evaluation of the effects of counseling and education in diabetes management. Diabetes Spectr\u202f: A Publ Am Diabetes Assoc. 2014;27(4):235\u201343. https:\/\/doi.org\/10.2337\/diaspect.27.4.235. (PubMedPMID:25647045;PubMedCentralPMCID:PMC4231931).","journal-title":"Diabetes Spectr : A Publ Am Diabetes Assoc"},{"issue":"6","key":"1909_CR43","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.9225","volume":"20","author":"RM Turner","year":"2018","unstructured":"Turner RM, Ma Q, Lorig K, Greenberg J, DeVries AR. Evaluation of a diabetes self-management program: claims analysis on comorbid illnesses, health care utilization, and cost. J M\u00e9d Internet Res. 2018;20(6):e207. https:\/\/doi.org\/10.2196\/jmir.9225. (PubMedPMID:29934284;PubMedCentralPMCID:PMC6035341).","journal-title":"J M\u00e9d Internet Res"},{"issue":"6","key":"1909_CR44","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1089\/pop.2019.0184","volume":"23","author":"D Barthold","year":"2020","unstructured":"Barthold D, Chiguluri V, Gumpina R, Sweet CC, Pieratt J, Cordier T, et\u00a0al. Health care utilization and medical cost outcomes from a digital diabetes prevention program in a medicare advantage population. Popul Heal Manag. 2020;23(6):414\u201321. https:\/\/doi.org\/10.1089\/pop.2019.0184. (PubMed PMID: 31928515).","journal-title":"Popul Heal Manag"},{"issue":"2","key":"1909_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.36469\/jheor.2020.14529","volume":"7","author":"CC Sweet","year":"2020","unstructured":"Sweet CC, Jasik CB, Diebold A, DuPuis A, Jendretzke B. Cost savings and reduced health care utilization associated with participation in a digital diabetes prevention program in an adult workforce population. J Heal Econ Outcomes Res. 2020;7(2):139\u201347. https:\/\/doi.org\/10.36469\/jheor.2020.14529. (PubMedPMID:32884964;PubMedCentralPMCID:PMC7458495).","journal-title":"J Heal Econ Outcomes Res"},{"issue":"9","key":"1909_CR46","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jamainternmed.2022.2947","volume":"182","author":"MJ Crowley","year":"2022","unstructured":"Crowley MJ, Tarkington PE, Bosworth HB, Jeffreys AS, Coffman CJ, Maciejewski ML, et\u00a0al. Effect of a comprehensive telehealth intervention vs telemonitoring and care coordination in patients with persistently poor type 2 diabetes control. JAMA Intern Med. 2022;182(9):943\u201352. https:\/\/doi.org\/10.1001\/jamainternmed.2022.2947. (PubMedPMID:35877092;PubMedCentralPMCID:PMC9315987).","journal-title":"JAMA Intern Med"},{"issue":"1","key":"1909_CR47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s12913-018-3274-8","volume":"18","author":"PA Lee","year":"2018","unstructured":"Lee PA, Greenfield G, Pappas Y. The impact of telehealth remote patient monitoring on glycemic control in type 2 diabetes: a systematic review and meta-analysis of systematic reviews of randomised controlled trials. BMC Heal Serv Res. 2018;18(1):495. https:\/\/doi.org\/10.1186\/s12913-018-3274-8. (PubMedPMID:29940936;PubMedCentralPMCID:PMC6019730).","journal-title":"BMC Heal Serv Res"},{"issue":"6","key":"1909_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.6764","volume":"3","author":"MG Perri","year":"2020","unstructured":"Perri MG, Shankar MN, Daniels MJ, Durning PE, Ross KM, Limacher MC, et\u00a0al. Effect of telehealth extended care for maintenance of weight loss in rural US communities. JAMA Netw Open. 2020;3(6):e206764. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.6764. (PubMedPMID:32539150;PubMedCentralPMCID:PMC7296388).","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1909_CR49","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/oby.23117","volume":"29","author":"CM Horstman","year":"2021","unstructured":"Horstman CM, Ryan DH, Aronne LJ, Apovian CM, Foreyt JP, Tuttle HM, et\u00a0al. Return on investment: medical savings of an employer-sponsored digital intensive lifestyle intervention for weight loss. Obesity. 2021;29(4):654\u201361. https:\/\/doi.org\/10.1002\/oby.23117. (PubMedPMID:33759385;PubMedCentralPMCID:PMC8252728).","journal-title":"Obesity"},{"key":"1909_CR50","doi-asserted-by":"publisher","DOI":"10.2196\/47473","volume":"11","author":"ES Mitchell","year":"2023","unstructured":"Mitchell ES, Fabry A, Ho AS, May CN, Baldwin M, Blanco P, et\u00a0al. The impact of a digital weight loss intervention on health care resource utilization and costs compared between users and nonusers with overweight and obesity: retrospective analysis study. JMIR mHealth uHealth. 2023;11:e47473. https:\/\/doi.org\/10.2196\/47473. (PubMedPMID:37616049;PubMedCentralPMCID:PMC10485704).","journal-title":"JMIR mHealth uHealth"},{"issue":"9","key":"1909_CR51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1002\/oby.24337","volume":"33","author":"C Tak","year":"2025","unstructured":"Tak C, Thompson P, Morse JL, McCallum M. Health care resource utilization and health care costs among digital weight-loss intervention participants and nonparticipants. Obesity. 2025;33(9):1637\u201344. https:\/\/doi.org\/10.1002\/oby.24337. (PubMedPMID:40808402;PubMedCentralPMCID:PMC12381601).","journal-title":"Obesity"},{"issue":"6","key":"1909_CR52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1097\/mlr.0b013e318286e437","volume":"51","author":"M Bilger","year":"2013","unstructured":"Bilger M, Finkelstein EA, Kruger E, Tate DF, Linnan LA. The effect of weight loss on health, productivity, and medical expenditures among overweight employees. M\u00e9d Care. 2013;51(6):471\u20137. https:\/\/doi.org\/10.1097\/mlr.0b013e318286e437. (PubMedPMID:23632594;PubMedCentralPMCID:PMC3654027).","journal-title":"M\u00e9d Care"},{"issue":"7","key":"1909_CR53","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13227","volume":"22","author":"V Brown","year":"2021","unstructured":"Brown V, Tran H, Downing KL, Hesketh KD, Moodie M. A systematic review of economic evaluations of web-based or telephone-delivered interventions for preventing overweight and obesity and\/or improving obesity-related behaviors. Obes Rev. 2021;22(7):e13227. https:\/\/doi.org\/10.1111\/obr.13227. (PubMed PMID: 33763956).","journal-title":"Obes Rev"},{"key":"1909_CR54","unstructured":"Peterson-KFF. How do prices of drugs for weight loss in the U.S. compare to peer nations\u2019 prices? [Internet]. 2023 [cited 2025 Oct 25]. Report No. Available from: https:\/\/www.healthsystemtracker.org\/brief\/prices-of-drugs-for-weight-loss-in-the-us-and-peer-nations\/."},{"key":"1909_CR55","doi-asserted-by":"publisher","unstructured":"Wennberg D, Coetzer H, Marr A, Margiotta C, Hashmi R, Kay J, et\u00a0al. The real-world costs of GLP-1 receptor agonist treatment. medRxiv preprint. https:\/\/doi.org\/10.1101\/2025.10.24.25338255v1.","DOI":"10.1101\/2025.10.24.25338255v1"},{"key":"1909_CR56","doi-asserted-by":"crossref","unstructured":"Bock S, Moshfegh J, Zhang J. Weighing the impacts of GLP-1s: quasi-experimental evidence from provider adoption [Internet]. 2026. Available from: https:\/\/www.nber.org\/papers\/w34667.","DOI":"10.3386\/w34667"},{"key":"1909_CR57","doi-asserted-by":"crossref","unstructured":"Wing C, Cai ST, Sacks D, Simon K. Do GLP-1 medications pay for themselves? [Internet]. 2026. Available from: https:\/\/www.nber.org\/system\/files\/working_papers\/w34678\/w34678.pdf.","DOI":"10.3386\/w34678"},{"issue":"10","key":"1909_CR58","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1111\/dom.16627","volume":"27","author":"N Gupta","year":"2025","unstructured":"Gupta N, Babyak A, Chorbajian A, Tardio V, Ballreich J, Dasgupta K. A cost-effectiveness analysis of behavioural, pharmacological, and surgical obesity treatments in Canada. Diabetes, Obes Metab. 2025;27(10):5748\u201360. https:\/\/doi.org\/10.1111\/dom.16627. (PubMedPMID:40686094;PubMedCentralPMCID:PMC12409247).","journal-title":"Diabetes, Obes Metab"},{"key":"1909_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/dom.71086","author":"SJ Athinarayanan","year":"2026","unstructured":"Athinarayanan SJ, Bjornstad P, Shanmugam PV, Weimbs T, Wolfberg AJ, Volek JS, et\u00a0al. Effectiveness of telehealth low-carbohydrate intervention in preventing chronic kidney disease: a real-world, retrospective, matched cohort study. Diabetes Obes Metab. 2026. https:\/\/doi.org\/10.1111\/dom.71086. (PubMed PMID: 42464019).","journal-title":"Diabetes Obes Metab"},{"key":"1909_CR60","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000001713","author":"SJ Athinarayanan","year":"2026","unstructured":"Athinarayanan SJ, Wolfberg AJ, Shanmugam PV, Hameed BA, Bonacini M. Reduced risk of liver-related events among patients receiving individualized nutrition-focused remote care in the United States. Hepatology. 2026. https:\/\/doi.org\/10.1097\/hep.0000000000001713. (PubMed PMID: 41842839).","journal-title":"Hepatology"},{"key":"1909_CR61","unstructured":"KFF. 2025 Employer Health Benefits Survey [Internet]. 2025 Oct [cited 2026 Feb 23]. Report No. Available from: https:\/\/www.kff.org\/health-costs\/2025-employer-health-benefits-survey\/#f4063214-84af-4643-b5e9-e2fa9274aa92."},{"issue":"12","key":"1909_CR62","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1111\/dom.14512","volume":"23","author":"K Suissa","year":"2021","unstructured":"Suissa K, Schneeweiss S, Lin KJ, Brill G, Kim SC, Patorno E. Validation of obesity-related diagnosis codes in claims data. Diabetes, Obes Metab. 2021;23(12):2623\u201331. https:\/\/doi.org\/10.1111\/dom.14512. (PubMedPMID:34338404;PubMedCentralPMCID:PMC8578343).","journal-title":"Diabetes, Obes Metab"},{"issue":"6","key":"1909_CR63","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/0145721720964585","volume":"46","author":"MC Jackson","year":"2020","unstructured":"Jackson MC, Dai S, Skeete RA, Owens-Gary M, Cannon MJ, Smith BD, et\u00a0al. An examination of gender differences in the national diabetes prevention program\u2019s lifestyle change program. Diabetes Educ. 2020;46(6):580\u20136. https:\/\/doi.org\/10.1177\/0145721720964585. (PubMedPMID:33063641;PubMedCentralPMCID:PMC7802597).","journal-title":"Diabetes Educ"},{"issue":"2","key":"1909_CR64","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/1557988316681221","volume":"11","author":"MM Crane","year":"2016","unstructured":"Crane MM, Jeffery RW, Sherwood NE. Exploring gender differences in a randomized trial of weight loss maintenance. Am J Men\u2019s Heal. 2016;11(2):369\u201375. https:\/\/doi.org\/10.1177\/1557988316681221. (PubMedPMID:27923968;PubMedCentralPMCID:PMC5313337).","journal-title":"Am J Men\u2019s Heal"},{"issue":"6","key":"1909_CR65","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/oby.2011.140","volume":"20","author":"SL Pagoto","year":"2012","unstructured":"Pagoto SL, Schneider KL, Oleski JL, Luciani JM, Bodenlos JS, Whited MC. Male inclusion in randomized controlled trials of lifestyle weight loss interventions. Obesity. 2012;20(6):1234\u20139. https:\/\/doi.org\/10.1038\/oby.2011.140. (PubMed PMID: 21633403).","journal-title":"Obesity"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01909-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-026-01909-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-026-01909-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:23:46Z","timestamp":1790655826000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-026-01909-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":65,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1909"],"URL":"https:\/\/doi.org\/10.1007\/s13300-026-01909-w","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"value":"1869-6953","type":"print"},{"value":"1869-6961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"2 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Priya Shanmugam, Shaminie Athinarayanan, and Adam Wolfberg are employees of Virta Health and hold stock or stock options in the company. Rebecca Adams is a former employee of Virta Health and holds stock or stock options in the company. Jeromie Ballreich received consulting fees from Virta Health for his contribution to the work.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was a retrospective analysis of deidentified administrative claims and program data licensed from KomodoHealth. The data was deidentified using the Expert Determination deidentification standard as specified by Health Insurance Portability and Accountability Act (HIPAA) Title 45 CFR Part 164.514b1. Because the data were deidentified and the study involved secondary analysis of existing records without direct participant contact or intervention, ethics committee approval and informed consent were not required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}